EDC for small clinical studies: lean cohorts, rapid build, and 21 CFR Part 11–aligned controls without enterprise cost.
21 CFR Part 11–aligned · HIPAA-aligned security · No credit card required
For large programs with dedicated teams for each function, managing separate systems for consent, EDC, ePRO, and safety reporting is burdensome but manageable. For small studies, it can be prohibitive. When the same coordinator is responsible for consenting participants, entering CRF data, setting up ePRO, and reporting adverse events, toggling between separate systems creates friction, increases error risk, and consumes time that could be spent on enrollment and participant care. Capture integrates all of these functions in one platform. The coordinator consents a participant, enters screening data, schedules visits, and captures safety information without leaving the system. The investigator reviews data and signs off on CRFs in the same interface. The data manager or monitor reviews data quality and raises queries from the same dataset. This integration is not just a convenience—it ensures that the audit trail is complete and continuous across all data types, which simplifies compliance documentation and makes the study inspection-ready from the start.
Speed to first patient is often the most critical operational metric for small studies. Whether driven by grant timelines, investor milestones, or competitive enrollment windows, delays in study startup directly impact the program. Capture is designed for rapid deployment: study builders configure CRFs, visit schedules, consent forms, and edit checks through the browser without waiting for vendor development cycles. For non-regulated or lower-risk studies, teams can configure and go live within days. For regulated studies that require sponsor validation, Capture provides sandbox environments for UAT and testing before production deployment, along with documentation to support installation qualification (IQ), operational qualification (OQ), and performance qualification (PQ). Even with validation in scope, the configuration-driven approach means that the EDC build itself is typically completed in weeks rather than months.
In large Phase 3 trials, statistical power provides some tolerance for data quality issues—missing values or inconsistencies in a few records may not materially affect the primary analysis. In small studies, the opposite is true: with limited sample sizes, every data point contributes meaningfully to the analysis. A single missing primary endpoint value or an unresolved safety query can weaken your results or raise questions during regulatory review. Capture addresses this by building data quality controls into the point of entry. Edit checks fire in real time as coordinators enter data, catching discrepancies, out-of-range values, and missing required fields before they become downstream issues. Query workflows enable monitors and data managers to flag and resolve issues promptly. And because all data—CRFs, consent, ePRO, and safety—flows into one dataset, there are no gaps from cross-system reconciliation that might leave data quality issues undetected.
Overview
Small clinical studies—whether pilot, feasibility, Phase 1, early Phase 2, or investigator-initiated—need EDC that fits cohort size and budget without compromising on data integrity or regulatory compliance. These studies represent the broadest category of clinical research: from a 10-patient pharmacokinetics study at a single academic center to a 75-patient early efficacy trial run across three community hospitals. What they share is a need for lean, practical data capture infrastructure that can be deployed quickly and operated by small teams. The challenge for small study teams is finding a system that meets regulatory expectations without enterprise-scale costs and implementation timelines. Sponsors, ethics committees, and health authorities expect 21 CFR Part 11–aligned controls, complete audit trails, and HIPAA-aligned security regardless of study size. At the same time, small study budgets cannot absorb per-seat licensing fees, multi-month implementations, or the cost of separate systems for consent, EDC, ePRO, and safety reporting. Capture provides EDC, eConsent, ePRO, and safety in one platform with 21 CFR Part 11–aligned controls and HIPAA-aligned infrastructure. The platform is designed so that small studies run with the same data integrity as larger ones, but with a setup and operational footprint that matches the team size and budget. Study builders configure CRFs, visit schedules, consent forms, and edit checks through the browser, without custom development. Coordinators enter data through a modern web interface that requires minimal training. And data managers export clean, analysis-ready datasets without extensive programming effort. Because Capture is a single integrated platform, small study teams avoid the common trap of cobbling together separate tools for different data types—a practice that creates reconciliation burden, duplicate validation work, and gaps in the audit trail that become problematic during monitoring visits or regulatory inspections.
Small studies still require audit trails, access controls, and data integrity for regulatory and sponsor review. The data from a 20-patient pilot or a 50-patient feasibility study may directly inform go/no-go decisions worth millions in development investment. Incomplete or inconsistent data at this stage can lead to flawed conclusions, delayed programs, or regulatory questions that are expensive to resolve later. Enterprise EDC platforms often price by seat, module, or site count—models that create cost-to-value misalignment for small studies. Implementation timelines designed for multi-hundred-site global programs do not fit the urgency of a small study that needs to enroll its first patient in weeks, not months. And feature sets built for late-phase complexity add training burden and operational friction for small teams that need simplicity. At the opposite end, using spreadsheets, generic form builders, or paper CRFs may seem expedient for small studies, but these approaches lack the audit trail, access control, and electronic signature capabilities that regulators and sponsors expect. Data captured in non-compliant systems may need to be recaptured or extensively reconciled before it can be used in regulatory submissions. Capture is built for studies of any size: one platform, one audit trail, and pricing that scales with your study rather than enterprise licensing. Small teams get the compliance controls they need without the overhead they do not.
FAQ
Explore the platform with a free sandbox. No sales call required.